[Form 4] SMITH & WESSON BRANDS, INC. Insider Trading Activity
Michelle Lohmeier, a director of Smith & Wesson Brands, Inc. (SWBI), reported an acquisition of 12,711 shares of common stock via restricted stock units on 09/15/2025. The reported transaction shows a $0 price per share because the shares were granted as RSUs, and Lohmeier's beneficial ownership following the grant is 38,161 shares held directly. The RSUs vest 1/12th on the 15th day of each month after grant, with 100% of vested shares to be delivered on the one-year anniversary of the grant. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
- Director received 12,711 restricted stock units, increasing direct beneficial ownership to 38,161 shares
- Vesting schedule is time-based (1/12th monthly) with full delivery mechanics specified, providing clarity on timing of share delivery
- None.
Insights
TL;DR: Director received 12,711 RSUs, raising direct ownership to 38,161 shares; transaction appears to be a routine equity grant.
The Form 4 discloses a non-derivative award of 12,711 common shares issued as restricted stock units on 09/15/2025 at no cash price, consistent with standard director compensation. The holding increases the director's direct beneficial ownership to 38,161 shares. Vesting is monthly in 1/12th increments with full delivery of vested shares at the one-year anniversary, indicating time-based vesting rather than performance-contingent vesting. For investors, this is a governance and compensation disclosure rather than an operational or financial performance signal.
TL;DR: Report documents a time-based RSU grant to a board member with monthly vesting and one-year delivery—standard governance practice.
The filing shows Michelle Lohmeier, a director, acquired 12,711 RSUs on 09/15/2025 increasing direct holdings to 38,161 shares. The vesting schedule (1/12th monthly, with delivery of vested shares on the one-year anniversary) is explicit and suggests standard retention-focused compensation. The disclosure was executed via power of attorney on 09/17/2025. There are no indications of accelerated vesting, performance conditions, or derivative instruments in this filing.